25 Aug 2020 Governance

Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK

After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.

Angela was responsible for driving through the merger with Leuka in November 2019, and is now leaving the charity in a strong position to build on the remarkable transformation she engineered.

She has been a valued Co CEO of the merged charity and a visionary sole CEO of the original charity. We thank her for her outstanding work on our behalf and wish her the very best in the future.

TV baker Juliet Sear announced as Leukaemia UK Ambassador

6 March 2024

TV baker Juliet Sear announced as Leukaemia UK Ambassador

Leukaemia UK is excited to announce long-time supporter Juliet Sear as their latest celebrity Ambassador. Juliet, who has been an enthusiastic supporter of Leukaemia UK for several years now, wanted…

Leukaemia UK announces John Goldman Fellows for 2022

8 November 2022

Leukaemia UK announces John Goldman Fellows for 2022

Leukaemia UK has awarded their prestigious John Goldman Fellow research grants to four outstanding early-career researchers seeking to advance our understanding of and ability to treat blood cancer. Leukaemia UK…

Leukaemia UK’s Patient Care Pioneer Award fuels innovative research to revolutionize ‘watch and wait’ approach

18 November 2024

Leukaemia UK’s Patient Care Pioneer Award fuels innovative research to revolutionize ‘watch and wait’ approach

Leukaemia UK is excited to announce Professor Francesco Forconi from University Hospital Southampton (UHS) as the first recipient of its Patient Care Pioneer Award. Through this new funding initiative, Professor…

Local eateries can help to cook up change with new charity initiative

15 May 2024

Local eateries can help to cook up change with new charity initiative

Pubs, bars and restaurants across the country are being called upon to get involved with Leukaemia UK’s Cooking Up Change to raise money for vital research into leukaemia and related…